World leading hospitals Peter Mac & US Sloan Kettering collaboration to trial Optiscan’s leading Cancer Imaging System

Highlights

  • The Melbourne Dental School (University of Melbourne) is seeking ethics approval for the use of Optiscan’s clinical imaging system as part of a human clinical trial to diagnose cancerous change in oral mucosa at the earliest possible stage (Oral Cancer Trial)
  • Royal Melbourne Hospital, Peter MacCallum Cancer Centre, Memorial Sloan Kettering Cancer Centre and Australian Centre for Oral Oncology Research & Education (Collaborators) are collaborators in the Oral Cancer Trial
  • 2nd Oral Cancer Clinical Trial by World-Leading Hospitals targeting Oral Cancer Screening using the Optiscan system

Full Details –  www.asx.com.au/asx/share-price-research/company/OIL